RaySearch Laboratories (Sweden)

RaySearch Laboratories (Sweden)

RaySearch Laboratories is a Swedish medical technology company that develops software used in radiation therapy of cancer. The company markets its products worldwide and has subsidiaries in the United States, Singapore, Belgium, France, Germany, and the United Kingdom. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for RaySearch Laboratories (Sweden), Sweden, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

55%


Total
Publications

308


Total Open
Publications

170


Total
Citations

7.3K


Open Access
Percentage

55%


Total
Publications

308


Total Open
Publications

170


Total
Citations

7.3K

Wikipedia

Website

download

Breakdown

25% 23% 7% 45%

Publisher Open

25%

Both

23%

Other Platform Open

7%

Closed

45%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

30%OA Journal

OA Journal 30%

44

Hybrid 41%

61

No Guarantees 29%

42

Other Platform Open

Domain 49%

47

Institution 40%

38

Preprint 15%

14

Other Internet 5%

5

Public 4%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
47
arXiv
Preprint
13
DANS - Data Archiving and Networked Services
Institution
9
Digital Access to Libraries
Institution
8
Konstfack University of Arts, Crafts, and Design - Publications
Institution
7
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
5
DOI
Other Internet
5
Figshare
Public
3
Elsevier - Scopus
Institution
3
University of Modena and Reggio Emilia - IRIS UNIMORE
Institution
2
1 / 3

Data updated 18 August 2025

Share

Share

Share